In Vitro Platform for Neurodegenerative Diseases
Explore Drug Knowledge in Pathological Phenotypes and Targets
Neurodegenerative disorder is a challenging therapeutic field defined as an unmet need. Investigating new targets and leveraging target combinations offer opportunities for better efficacy, safety, disease management, and life quality for patients. Eurofins Discovery provides three cost-effective panels for neurodegeneration, Alzheimer’s disease (AD), and Parkinson’s disease (PD) to evaluate candidates that modulate neurite and the multi-targeted mechanism of action (MOA).